# B Capital's Biotech Investments: 33 Startups in Its Portfolio (2026)

> The 33 Biotech startups B Capital has backed, by stage: $2.6B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/b-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Series C and later

11

- [*IM* Insilico Medicine](https://millionrounds.com/company/insilico-medicine)
- [Unchained Labs](https://millionrounds.com/company/unchained-labs)
- [Carrick Therapeutics](https://millionrounds.com/company/carrick-therapeutics)
- [HotSpot Therapeutics](https://millionrounds.com/company/hotspot-therapeutics)
- [Acepodia](https://millionrounds.com/company/acepodia)
- [*T* Teligene](https://millionrounds.com/company/teligene)
- [Evidation Health](https://millionrounds.com/company/evidation-health)
- [*LT* Laekna Therapeutics](https://millionrounds.com/company/laekna-therapeutics)
- [CXA Group](https://millionrounds.com/company/cxa-group)
- [*TM* TYK Medicines](https://millionrounds.com/company/tyk-medicines)
- [ExoCoBio](https://millionrounds.com/company/exocobio)

## Stage not reported

9

- [Taysha Gene Therapies](https://millionrounds.com/company/taysha-gene-therapies)
- [Evommune](https://millionrounds.com/company/evommune)
- [Cue Biopharma](https://millionrounds.com/company/cue-biopharma)
- [Aetion](https://millionrounds.com/company/aetion)
- [HaploX Biotechnology](https://millionrounds.com/company/haplox-biotechnology)
- [*PI* Pharos iBio Co.](https://millionrounds.com/company/pharos-ibio-co)
- [Moonlight Therapeutics](https://millionrounds.com/company/moonlight-therapeutics)
- [Oncocross](https://millionrounds.com/company/oncocross)
- [*MB* MK Biotech](https://millionrounds.com/company/mk-biotech)

## Series B

7

- [Nuvig Therapeutics](https://millionrounds.com/company/nuvig-therapeutics)
- [ARTBIO](https://millionrounds.com/company/artbio)
- [OncoMyx Therapeutics](https://millionrounds.com/company/oncomyx-therapeutics)
- [Provention Bio](https://millionrounds.com/company/provention-bio)
- [Tiny Health](https://millionrounds.com/company/tiny-health)
- [*LB* LISCure Biosciences](https://millionrounds.com/company/liscure-biosciences)
- [Notable Labs](https://millionrounds.com/company/notable-labs)

## Series A

6

- [Volastra Therapeutics](https://millionrounds.com/company/volastra-therapeutics)
- [Faeth Therapeutics](https://millionrounds.com/company/faeth-therapeutics)
- [Vidacom](https://millionrounds.com/company/vidacom)
- [*ML* Myia Labs](https://millionrounds.com/company/myia-labs)
- [Micronbrane Medical](https://millionrounds.com/company/micronbrane-medical)
- [PeLeMed](https://millionrounds.com/company/pelemed)

## Segment by segment

### Series C and later

11 startups · $1.3B raised

- [*IM* **Insilico Medicine**](https://millionrounds.com/company/insilico-medicine) Hong Kong SAR China $392M
- [**Unchained Labs**](https://millionrounds.com/company/unchained-labs) Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it. United States $193M
- [**Carrick Therapeutics**](https://millionrounds.com/company/carrick-therapeutics) Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. United Kingdom $155M
- [**HotSpot Therapeutics**](https://millionrounds.com/company/hotspot-therapeutics) HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment. United States $145M
- [**Acepodia**](https://millionrounds.com/company/acepodia) Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer. United States $100M
- [*T* **Teligene**](https://millionrounds.com/company/teligene) Teligene is a drug discovery company edicating to developing innovative small-molecule drugs. China $93M
- [**Evidation Health**](https://millionrounds.com/company/evidation-health) We enable and empower everyone to participate in better health outcomes. United States $61M
- [*LT* **Laekna Therapeutics**](https://millionrounds.com/company/laekna-therapeutics) Laekna Therapeutics is a biotech company focusing on drug discovery and development. China $61M

### Stage not reported

9 startups · $724M raised

- [**Taysha Gene Therapies**](https://millionrounds.com/company/taysha-gene-therapies) Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system. United States $400M
- [**Evommune**](https://millionrounds.com/company/evommune) Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms. United States $125M
- [**Cue Biopharma**](https://millionrounds.com/company/cue-biopharma) Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease. United States $76M
- [**Aetion**](https://millionrounds.com/company/aetion) Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers. United States $74M
- [**HaploX Biotechnology**](https://millionrounds.com/company/haplox-biotechnology) HaploX Biotechnology is a genetic testing and precision medicine company based in Shenzhen, Guangdong, China. China $32M
- [*PI* **Pharos iBio Co.**](https://millionrounds.com/company/pharos-ibio-co) Pharos iBio Co. - $13M
- [**Moonlight Therapeutics**](https://millionrounds.com/company/moonlight-therapeutics) Moonlight Therapeutics is a clinical-stage biotechnology company based in Atlanta, Georgia, dedicated to developing treatments for United States $2.4M
- [**Oncocross**](https://millionrounds.com/company/oncocross) Oncocross is a Biopharmaceutical Company. - $882K

### Series B

7 startups · $491M raised

- [**Nuvig Therapeutics**](https://millionrounds.com/company/nuvig-therapeutics) Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune. United States $161M
- [**ARTBIO**](https://millionrounds.com/company/artbio) ARTBIO is a clinical-stage biotechnology company founded in 2021, focused on developing alpha radioligand therapies for targeted c United States $132M
- [**OncoMyx Therapeutics**](https://millionrounds.com/company/oncomyx-therapeutics) OncoMyx Therapeutics is a biotechnology company based in Phoenix, Arizona, founded in 2018. United States $75M
- [**Provention Bio**](https://millionrounds.com/company/provention-bio) Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics. United States $63M
- [**Tiny Health**](https://millionrounds.com/company/tiny-health) Tiny Health is a wellness company that specializes in at-home gut and vaginal microbiome testing for individuals of all ages, from United States $33M
- [*LB* **LISCure Biosciences**](https://millionrounds.com/company/liscure-biosciences) LISCure Biosciences is a biotech company that researches and develops bacteria-mediated immunotherapy. South Korea $17M
- [**Notable Labs**](https://millionrounds.com/company/notable-labs) Notable Labs provides personalized drug combination testing service for cancer patients. United States $10M

### Series A

6 startups · $88M raised

- [**Volastra Therapeutics**](https://millionrounds.com/company/volastra-therapeutics) Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers. United States $30M
- [**Faeth Therapeutics**](https://millionrounds.com/company/faeth-therapeutics) Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients. United States $25M
- [**Vidacom**](https://millionrounds.com/company/vidacom) Vidacom specializes in the biological manufacture of natural goods. - $14M
- [*ML* **Myia Labs**](https://millionrounds.com/company/myia-labs) United States $10M
- [**Micronbrane Medical**](https://millionrounds.com/company/micronbrane-medical) Micronbrane Medical is a biotechnology startup based in Taiwan, founded in 2020. Taiwan $4.5M
- [**PeLeMed**](https://millionrounds.com/company/pelemed) PeLeMed is a drug development company working on the discovery of anti-cancer drugs. South Korea $4.2M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names B Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **B Capital's AI portfolio** 68 startups · $21B](https://millionrounds.com/portfolio-maps/b-capital-ai-portfolio)[Sector portfolio **B Capital's Fintech portfolio** 33 startups · $3.5B](https://millionrounds.com/portfolio-maps/b-capital-fintech-portfolio)[Sector portfolio **B Capital's Healthtech portfolio** 29 startups · $2.4B](https://millionrounds.com/portfolio-maps/b-capital-healthtech-portfolio)[Sector portfolio **B Capital's Big Data & Analytics portfolio** 17 startups · $884M](https://millionrounds.com/portfolio-maps/b-capital-big-data-analytics-portfolio)[Portfolio map **B Capital portfolio map** 234 startups · $37B](https://millionrounds.com/portfolio-maps/b-capital-portfolio-map)[Co-investors **Who invests with B Capital** 234 co-investors](https://millionrounds.com/portfolio-maps/b-capital-co-investors)

## Raising from investors like B Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
